Switch to:
More From Other Websites
Sanofi: Effect of Genzyme's Multiple Sclerosis Treatment Lemtrada® (alemtuzumab) on Slowing Brain... Apr 23 2015
9:01 am Sanofi-Aventis: Effect of Genzyme's multiple sclerosis treatment Lemtrada (alemtuzumab) on... Apr 23 2015
Effect of Genzyme’s Multiple Sclerosis Treatment Lemtrada® (alemtuzumab) on Slowing Brain Atrophy... Apr 23 2015
Alnylam Reports Positive Patisiran Results, Shares Up - Analyst Blog Apr 22 2015
How a Stronger US Dollar Has Affected Large-Cap Stocks Apr 22 2015
Amgen: But What About the Biosimilars? Apr 22 2015
Sanofi-Aventis upgraded by Citigroup Apr 22 2015
Genzyme Initiates Phase 2a Clinical Trial to Evaluate Oral Therapy for Fabry Disease Apr 21 2015
Bristol's Opdivo Scores Again Against Lung Cancer Apr 17 2015
Actelion to Boost Progress of Specialty Immunology Pipeline - Analyst Blog Apr 16 2015
The Medicines Co.'s Kengreal Briefing Documents Positive - Analyst Blog Apr 14 2015
Fewer CEOs Fired and More Retired Save Shareholders Billions Apr 13 2015
Fewer CEOs Are Being Fired and That's Good News for Shareholders Apr 13 2015
Wave of interest in gene therapy brings Voyager a new $60M investment Apr 13 2015
Genzyme to Present New Long-Term Data on Aubagio® (teriflunomide) and Lemtrada® (alemtuzumab) at... Apr 13 2015
Trade Europe and a Strong USD with this ETF Apr 10 2015
Inverse Head and Shoulders Patterns Breaking Out Apr 09 2015
What Really Happens To Stocks When The Fed Tightens Monetary Policy? Apr 08 2015
FDA accepts Novo Nordisk's resubmitted application for insulin drug Apr 07 2015
Sanofi: Shantha will provide up to 37 million doses of Shan5(TM) Apr 07 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK